semaglutide cardiovascular outcomes news 2025 october Effects of on mortality, cardiovascular, and kidney across the cardio-kidney-metabolic continuum: a systematic review and meta-analysis | Diabetology Cardiovascular Risks after GLP-1 Discontinuation

Ligibel: The bariatric surgery literature is quite clear that weight loss can lead to a lower risk of developing cancer

Probiotics containing Lactobacillus and Bifidobacterium strains can accelerate healthy microbiome rebalancing

That compares with six cases in patients prescribed non-GLP-1 diabetes drugs, calculated as a cumulative rate of 1.8%

Taking semaglutide at roughly the same time each week helps maintain steady medication levels

They also slow down the movement of food through the stomach and curb appetite, thereby causing weight loss

Ask our sponsor, Perplexity, how far is the distance between Starbase and the SpaceX rocket